Clinical Trials mRNA Vaccines mRNA Technology Regulatory Approval Operation Warp Speed Vaccine Efficacy Immunology Vaccine Safety Research Funding FDA Approval COVID-19 Vaccines Moderna Adjuvanted Vaccines Thimerosal Safety Trials Polio Vaccine Viral Vaccines Norovirus Vaccine Vaccine Coverage Cervical Cancer Strain Selection Pfizer Vaccine Influenza Vaccines Combination Vaccines Research Regulatory Agencies Low-Dose Vaccines Adjuvants Collaboration Hepatitis B Vaccines Preservatives COVID-19 Approval Processes Federal Contracts HIV Vaccines Vaccine Composition Clinical Research Viral Mutations Vaccine Recommendations Efficacy Studies Paxlovid Quadrivalent Vaccine Vaccine Supply Chain Historical Context FDA Regulations Manufacturing RSV Vaccine Messenger RNA Vaccines Vaccine Design Conventional Vaccines Cancer Vaccines HPV Vaccine Research Centers Production Capacity Manufacturers Respiratory Syncytial Virus Research Pipelines Protein-based Vaccines Immune Response
Using nanodisc cryo-EM in a membrane-like environment revealed a mechanical opening step with potential to guide safer, more precise T cell therapies.
